Evidence map›Paper›PMID 26758079›Full record

ArticleImmunogenetics2016

Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes.

Trishna Manandhar, Heike Kunze-Schumacher, Trevor Huyton, Alexander A Celik, Rainer Blasczyk, Christina Bade-Doeding

Open access · hybridAbstract read
In one paragraph

Article in Immunogenetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Trishna ManandharHannover Medical School, Institute for Transfusion Medicine, Feodor-Lynen-Str. 5, 30625, Hannover, Germany.
Heike Kunze-SchumacherHannover Medical School, Institute for Transfusion Medicine, Feodor-Lynen-Str. 5, 30625, Hannover, Germany.
Trevor HuytonHannover Medical School, Institute for Transfusion Medicine, Feodor-Lynen-Str. 5, 30625, Hannover, Germany.
Alexander A CelikHannover Medical School, Institute for Transfusion Medicine, Feodor-Lynen-Str. 5, 30625, Hannover, Germany.
Rainer BlasczykHannover Medical School, Institute for Transfusion Medicine, Feodor-Lynen-Str. 5, 30625, Hannover, Germany.
Christina Bade-DoedingHannover Medical School, Institute for Transfusion Medicine, Feodor-Lynen-Str. 5, 30625, Hannover, Germany. bade-doeding.christina@mh-hannover.de.
Medizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Defining permissive and non-permissive mismatches for transplantation is a demanding challenge. Single mismatches at amino acid (AA) position 156 of human leucocyte antigen (HLA) class I have been described to alter the peptide motif, repertoire, or mode of peptide loading through differential interaction with the peptide-loading complex. Hence, a single mismatch can tip the balance and trigger an immunological reaction. HLA-B*35 subtypes have been described to evade the loading complex, 156 mismatch distinguishing B*35:01 and B*35:08 changes the binding groove sufficiently to alter the sequence features of the selected peptide repertoire. To understand the functional influences of residue 156 in B*35 variants, we analyzed the peptide binding profiles of HLA-B*35:01(156Leu), B*35:08(156Arg) and B*35:62(156Trp). The glycoprotein tapasin represents a target for immune evasions and functions within the multimeric peptide-loading complex to stabilize empty class I molecules and promote acquisition of high-affinity peptides. All three B*35 subtypes showed a tapasin-independent mode of peptide acquisition. HLA-B*35-restricted peptides of low- and high-binding affinities were recovered in the presence and absence of tapasin and subsequently sequenced utilizing mass spectrometry. The peptides derived from B*35 variants differ substantially in their features dependent on their mode of recruitment; all peptides were preferentially anchored by Pro at p2 and Tyr, Phe, Leu, or Lys at pΩ. However, the Trp at residue 156 altered the p2 motif to an Ala and restricted the pΩ to a Trp. Our results highlight the importance of understanding the impact of key micropolymorphism and how a single AA mismatch orchestrates the neighboring AAs.

Indexed as

Amino Acid MotifsAmino AcidsAmino Acid SubstitutionCell LineEndoplasmic ReticulumHematopoietic Stem Cell TransplantationHLA-B35 AntigenHumansMembrane Transport ProteinsPeptidesPolymorphism, GeneticProtein BindingAmino AcidsHLA-B35 AntigenMembrane Transport ProteinsPeptidestapasinHLA polymorphismPeptide-binding motifPeptide-loading complexTapasin

Identifiers

PMID26758079
PMCPMC4799800
OpenAlexW2237534001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.